Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Prostate Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    September 2025
  1. LONG Z, Chang Y, Zhu K, Chen Z, et al
    Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis?related genes (Review).
    Int J Oncol. 2025;67:77.
    PubMed     Abstract available


    March 2025
  2. MASUD N, Aldahish A, Iczkowski KA, Kale A, et al
    [Retracted] Zinc finger protein?like 1 is a novel neuroendocrine biomarker for prostate cancer.
    Int J Oncol. 2025;66:16.
    PubMed     Abstract available


    February 2025
  3. GRAVINA GL, Marampon F, Giusti I, Carosa E, et al
    [Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Int J Oncol. 2025;66:11.
    PubMed     Abstract available


    November 2024
  4. IIDA K, Zheng R, Shen R, Nanus DM, et al
    [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
    Int J Oncol. 2024;65:106.
    PubMed     Abstract available


  5. XU Y, Zhang G, Liu Y, Liu Y, et al
    Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review).
    Int J Oncol. 2024;65:104.
    PubMed     Abstract available


    September 2024
  6. ZHENG XM, Zhang P, Liu MH, Chen P, et al
    [Retracted] MicroRNA?30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
    Int J Oncol. 2024;65:82.
    PubMed     Abstract available


    February 2024
  7. NAEEM AA, Abdulsamad SA, Zeng H, He G, et al
    FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
    Int J Oncol. 2024;64:18.
    PubMed     Abstract available


  8. ZHONG K, Luo W, Li N, Tan X, et al
    CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
    Int J Oncol. 2024;64:20.
    PubMed     Abstract available


    January 2024
  9. SUN X, Xin S, Zhang Y, Jin L, et al
    [Corrigendum] Long non?coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Int J Oncol. 2024;64:5.
    PubMed     Abstract available


    November 2023
  10. FENG K, Liu C, Wang W, Kong P, et al
    Emerging proteins involved in castration?resistant prostate cancer via the AR?dependent and AR?independent pathways (Review).
    Int J Oncol. 2023;63:127.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.